The genes whose loss is predicted to be detrimental to EGFR-driven tumors (i.e., Keap1, Lkb1, and Nf2) are rarely co-mutated with EGFR in human lung adenocarcinoma as predicted (Fig. 6B). This evidence concerns the gene STK11 and lung adenocarcinoma.